Haldun OGUZ

Prof. Dr. Haldun OGUZ

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2021 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
NENecat Enver
Necat Enver
EAElad Azizli
Elad Azizli
SASevtap Akbulut
Sevtap Akbulut
ETEmel ÇADALLI TATAR
Emel ÇADALLI TATAR
MYMuhammed Kürşat Yelken
Muhammed Kürşat Yelken
HOHaldun OGUZ
Haldun OGUZ
To assess the inflammatory adverse reactions of vocal fold injection laryngoplasty with hyaluronic acid. This study was a retrospective chart review of patients who underwent vocal fold injection augmentation with HA injection from January 2005 to September 2016 in nine different institutions. Demographic data, indication for injection, injection techniques, types of injection material used, settings of procedure, and complications were reviewed. The types of complication, onset time, and management of complications were also noted. In all, 467 patients were identified. The majority of patients had been injected under general anesthesia (n = 382, 84.7%). For injection material, two different types of hyaluronic acid were used: hyaluronic acid alone or hyaluronic acid with dextranomer. Complications occurred in nine patients (1.9%). The majority of complications were inflammatory reactions (n = 7, 1.47 %). Main symptoms were dysphonia and/or dyspnea with an onset of 0 h to 3 weeks after the hyaluronic acid injection. Three patients were hospitalized, one of which was also intubated and observed in the intensive care unit for 24 hour. Systemic steroids and antibiotics were the main medical treatment in the majority of cases. There was no statistical difference in complication rates between patients who received hyaluronic acid and those who received hyaluronic acid with dextranomer (p = 0.220). hyaluronic acid with can be considered as a safe substance for the injection of vocal folds with a low risk of inflammatory reaction.

4 August 2022 in Journal of Voice
Verified
Journal Article
Closed access
PDF file
GNGulnur Nukusbekova
Gulnur Nukusbekova
DTDinara Toguzbayeva
Dinara Toguzbayeva
RHRamil Hashimli
Ramil Hashimli
HOHaldun OGUZ
Haldun OGUZ
STSaule Taukeleva
Saule Taukeleva

18 January 2021 in Turkish Archives of Otorhinolaryngology
Verified
Journal Article
Open access
HÇH. Bengü Çobanoğlu
H. Bengü Çobanoğlu
NENecati Enver
Necati Enver
SASevtap Akbulut
Sevtap Akbulut
EAE. Özlem Atmış
E. Özlem Atmış
HBHakan Birkent
Hakan Birkent
FÖFerhan Öz
Ferhan Öz
Laryngoscopy,endoscopic examination,COVID-19,pandemic,universal precautions

11 April 2026 in Journal of Voice
Verified
Journal Article
Closed access
RHRamil Hashimli
Ramil Hashimli
KSKamil Suleymanov
Kamil Suleymanov
KYKursat Yelken
Kursat Yelken
IDIlter Denizoglu
Ilter Denizoglu
HOHaldun OGUZ
Haldun OGUZ

9 November 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
EDEngin DURSUN
Engin DURSUN
EAEmine Altuntaş
Emine Altuntaş
İDİlter Denizoğlu
İlter Denizoğlu
GSGüleser SAYLAM
Güleser SAYLAM
CGCelil Gocer
Celil Gocer
HOHaldun OGUZ
Haldun OGUZ
Background: Presbylarynx describes the structural phenotype of an aging larynx, whereas presbyphonia refers to its clinically relevant perceptual and functional expression. Although vocal fold atrophy, bowing, and glottic insufficiency are common in older adults, their presence and severity do not consistently correspond to patient-reported voice impairments. Therefore, presbylaryngeal morphology should be interpreted within the broader context of compensatory capacity, physiological reserve, systemic health, and individual communication demands. Objective: This narrative review aims to provide a clinically oriented and multidimensional synthesis of presbylarynx, encompassing its terminology, morphological and functional characteristics, relationship with systemic aging, differential diagnosis, clinical assessment, management strategies, and emerging diagnostic and therapeutic approaches. Methods: A targeted literature search of PubMed/MEDLINE, Scopus, and Web of Science was conducted in August 2026, with additional targeted searches and citation checking during revision. Relevant systematic and narrative reviews, clinical practice guidelines, consensus statements, prospective and retrospective clinical studies, translational investigations, and landmark publications addressing the presbylarynx, presbyphonia, vocal fold atrophy, laryngeal aging, assessment, and treatment were reviewed and synthesized narratively. No formal systematic review protocol, duplicate screening, standardized data extraction, or risk-of-bias assessment was performed. Results: Presbylarynx encompasses age-related alterations in the vocal fold epithelium, lamina propria, intrinsic laryngeal musculature, and neuromuscular control, which may produce vocal fold atrophy, bowing, glottic insufficiency, and reduced vibratory efficiency. However, structural findings alone neither establish the cause of dysphonia nor determine the need for treatment. Clinical expression is modified by respiratory function, frailty, comorbidities, cognition, hearing status, compensatory behavior, and communication requirements. Assessment should integrate laryngeal morphology with patient-reported, auditory-perceptual, acoustic, aerodynamic, respiratory, and systemic findings, while excluding alternative and coexisting causes of dysphonia. Management should target meaningful functional impairment and may include observation, behavioral voice therapy, injection augmentation, durable medialization, or combined approaches within a flexible, nonlinear, and patient-centered pathway. Artificial intelligence, digital voice biomarkers, regenerative interventions, advanced biomaterials, and neuromuscular stimulation represent emerging opportunities; however, their clinical application remains limited by insufficient validation and predominantly preliminary or preclinical evidence. Conclusions: The presbylarynx is not inherently pathological or an indication for treatment. Its clinical significance emerges when age-related laryngeal changes contribute to meaningful limitations in voice function, communication, or quality of life. A multidimensional, system-aware, and function-driven approach is essential for accurate interpretation and individualized management. Future research should prioritize standardized definitions, reproducible phenotyping, comparable outcome measures, prospective comparative studies, and careful validation of new technologies.

9 November 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
EDEngin DURSUN
Engin DURSUN
EAEmine Altuntaş
Emine Altuntaş
HOHaldun OGUZ
Haldun OGUZ
SÖSelmin Karataylı ÖZGÜRSOY
Selmin Karataylı ÖZGÜRSOY
EAEsma Altan
Esma Altan
CGCelil Gocer
Celil Gocer
Chronic cough may persist despite appropriate treatment of associated conditions, creating uncertainty about the relevance of coexisting abnormalities and therapeutic priorities. This evidence-informed narrative review draws on searches of PubMed/MEDLINE, Scopus, and Web of Science and relevant guidelines to propose a mechanism-based multidisciplinary framework for adults, particularly those with refractory or unexplained chronic cough. The nine-step pathway integrates established disease assessment, characterization of cough hypersensitivity and laryngeal involvement, provisional weighting of treatable traits and modifiable contributors, targeted multidisciplinary input, individualized intervention, and reassessment. Within this proposed framework, findings are considered dominant, contributory, incidental, or currently inactive according to converging clinical evidence; insufficiently evaluated findings remain uncertain. Treatment response is interpreted by distinguishing improvement in the targeted trait from improvement in cough. Discordant or inadequate responses prompt reassessment of treatment adequacy and mechanistic relevance. Patient-reported outcomes, objective cough monitoring when available, and trait-specific measures inform treatment evaluation and subsequent re-phenotyping. The weighting categories and integrated pathway represent the authors’ conceptual synthesis and have not been prospectively validated. Their reproducibility, feasibility, clinical effectiveness, and cost-effectiveness require evaluation.